MyFinsight
Home
Blog
About
Contact
Download
Download image
Collaboration revenue -
related party
$47,033K
(74.04%↑ Y/Y)
Collaboration revenue
$12,586K
(3292.45%↑ Y/Y)
Grant revenue
$7,183K
(-65.10%↓ Y/Y)
Total revenues
$66,802K
(39.24%↑ Y/Y)
Interest income
$2,512K
(-46.95%↓ Y/Y)
Other income
(expense), net
$7K
(-88.33%↓ Y/Y)
Income (loss) from
operations
$6,314K
(108.61%↑ Y/Y)
Total other income,
net
$2,519K
(-47.47%↓ Y/Y)
Total operating
expenses
$60,488K
(-50.15%↓ Y/Y)
Net income (loss)
before income taxes
$8,833K
(112.88%↑ Y/Y)
Research and development
$38,467K
(-60.24%↓ Y/Y)
General and
administrative
$21,176K
(-10.66%↓ Y/Y)
Impairment of long-term
asset
$587K
Restructuring
$258K
(-70.58%↓ Y/Y)
Net income (loss)
and comprehensive...
$8,572K
(112.50%↑ Y/Y)
Income tax expense
$261K
Severance and other
employee costs
$258K
Back
Back
Income Statement
source: myfinsight.com
Spero Therapeutics, Inc. (SPRO)
Spero Therapeutics, Inc. (SPRO)